Victoria
Australia
Biomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation
UGGT inhibitor, CtUGGTGT24, 5-[(morpholin-4-yl)methyl]quinolin-8-ol, X-ray crystallography, fragment-based lead discovery, saturation transfer difference NMR spectroscopy